Michael Marsh, MD
Otolaryngology · Fort Smith, ARNPI 1174547988
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,750 of the $3,977 with a category attached, or 69.1%. Stryker accounts for 89.6% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $2,987 and has fallen 96.6% since, to $101 in 2025.
Across 49 payments — averaging $81.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Regeneron Healthcare Solutions, Inc.$132
- GSK$88
- Intersect ENT, Inc.$66
- Sanofi$62
- Medtronic$36
- plus $29 from 2 others
What the payments were for
- Consulting fees$2,75069%
- Food & beverage$1,22731%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 28 | $3,565 |
| Regeneron Healthcare Solutions, Inc. | 6 | $132 |
| GSK | 5 | $88 |
| Intersect ENT, Inc. | 4 | $66 |
| Sanofi | 2 | $62 |
| Medtronic | 2 | $36 |
| Phadia US Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,977 in reported general payments places this provider in the 85th percentile of 72 otolaryngology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 76 | $4,867 |
| Cefdinir | 90 | $2,825 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 21 | $2,312 |
| Fluticasone Propionate | 152 | $2,218 |
| Azelastine Hcl | 25 | $471 |
| Levofloxacin | 35 | $323 |
| Ondansetron OdtOndansetron | 38 | $159 |
| Tramadol Hcl | 51 | $145 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $70 |
| Triamcinolone Acetonide | 28 | $47 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $22 |
| Alprazolam | 30 | $18 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Fort Smith
- Michael GwartneyFort Smith$3K
- Gary HighfillFort Smith$2K
- Patricia BellHarrison$82K
- Cory VaughnSpringdale$7K
- Jeffrey KirschConway$6K
- Patrick FraleyConway$5K
- Sharon TomaskiEl Dorado$5K
- Tyler BoneJonesboro$5K
- Rafael MarreroConway$4K
- Matthew BridgesRogers$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.